Mannitol Injection IP 20% w/v

Therapeutic Use:

A hyperosmotic diuretic used to reduce intracranial and intraocular pressure, prevent acute kidney injury, and manage cerebral edema.

Mechanism of Action:

Promotes osmotic diuresis by drawing water into renal tubules, increasing urine output. Reduces swelling in the brain and eyes by extracting excess fluid.

Key Benefits:

✔ Effective for treating cerebral edema, glaucoma, and acute renal failure.
✔ Helps prevent kidney damage in critical conditions.

Regulatory Compliance:

WHO-GMP | EU-GMP | cGMP | GLP

Note: Approvals are currently under process with relevant authorities.

Mannitol Injection IP 20% w/v

Mannitol Injection IP 20% w/v

Therapeutic Use:

Mechanism of Action:

Key Benefits:

Regulatory Compliance:

Our Products

Factory Address:

Registered Office:

CIN: U24246MH2022PTC389085

CONTACT

Useful Link